Washington Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.8M Sell
105,717
-1,728
-2% -$402K 0.87% 30
2025
Q4
$22.2M Sell
107,445
-17,249
-14% -$3.41M 0.73% 33
2025
Q3
$23.1M Buy
124,694
+90
+0.1% +$15.4K 0.76% 33
2025
Q2
$19M Buy
124,604
+836
+0.7% +$129K 0.67% 41
2025
Q1
$20.5M Sell
123,768
-1,872
-1% -$293K 0.79% 35
2024
Q4
$18.2M Sell
125,640
-1,050
-0.8% -$163K 0.65% 43
2024
Q3
$20.5M Sell
126,690
-1,304
-1% -$208K 0.72% 39
2024
Q2
$18.7M Sell
127,994
-3,952
-3% -$588K 0.68% 43
2024
Q1
$20.9M Sell
131,946
-238
-0.2% -$37.9K 0.77% 33
2023
Q4
$20.7M Sell
132,184
-1,080
-0.8% -$166K 0.82% 28
2023
Q3
$20.8M Sell
133,264
-306
-0.2% -$50.5K 0.91% 23
2023
Q2
$22.1M Sell
133,570
-222
-0.2% -$35.8K 0.93% 24
2023
Q1
$20.7M Buy
133,792
+1,847
+1% +$298K 0.93% 27
2022
Q4
$23.3M Sell
131,945
-4,707
-3% -$813K 1.09% 22
2022
Q3
$22.3M Sell
136,652
-841
-0.6% -$142K 1.12% 22
2022
Q2
$24.4M Buy
137,493
+1,829
+1% +$326K 1.15% 22
2022
Q1
$24M Buy
135,664
+2,485
+2% +$423K 0.95% 26
2021
Q4
$22.8M Sell
133,179
-48,880
-27% -$8M 0.85% 30
2021
Q3
$29.4M Sell
182,059
-156
-0.1% -$26.6K 0.83% 37
2021
Q2
$30M Sell
182,215
-529
-0.3% -$87.6K 0.85% 35
2021
Q1
$30M Buy
182,744
+810
+0.4% +$131K 0.92% 32
2020
Q4
$28.6M Buy
181,934
+10,355
+6% +$1.53M 0.92% 31
2020
Q3
$25.5M Buy
171,579
+717
+0.4% +$106K 0.94% 28
2020
Q2
$23.8M Sell
170,862
-9,870
-5% -$1.44M 0.99% 27
2020
Q1
$23.7M Buy
180,732
+5,358
+3% +$760K 1.13% 24
2019
Q4
$25.6M Buy
175,374
+51,305
+41% +$6.96M 1.01% 31
2019
Q3
$16.4M Sell
124,069
-591
-0.5% -$77.9K 0.88% 33
2019
Q2
$17.4M Buy
124,660
+2,362
+2% +$327K 0.95% 32
2019
Q1
$17.1M Sell
122,298
-251
-0.2% -$33.6K 0.96% 30
2018
Q4
$15.8M Sell
122,549
-1,150
-0.9% -$160K 1.01% 26
2018
Q3
$17.1M Sell
123,699
-829
-0.7% -$110K 0.91% 31
2018
Q2
$15.1M Buy
124,528
+10,552
+9% +$1.32M 0.81% 39
2018
Q1
$14.6M Sell
113,976
-280
-0.2% -$37.8K 0.86% 37
2017
Q4
$16M Buy
114,256
+3,242
+3% +$452K 0.9% 39
2017
Q3
$14.4M Buy
111,014
+169
+0.2% +$22.4K 0.86% 42
2017
Q2
$14.7M Buy
110,845
+2,131
+2% +$272K 0.89% 41
2017
Q1
$13.5M Buy
108,714
+2,402
+2% +$287K 0.86% 45
2016
Q4
$12.2M Sell
106,312
-1,599
-1% -$185K 0.79% 50
2016
Q3
$12.7M Sell
107,911
-1,659
-2% -$201K 0.84% 49
2016
Q2
$13.3M Sell
109,570
-1,349
-1% -$153K 0.9% 47
2016
Q1
$12M Buy
110,919
+3,967
+4% +$411K 0.8% 51
2015
Q4
$11M Sell
106,952
-2,220
-2% -$223K 0.75% 48
2015
Q3
$10.2M Sell
109,172
-3,493
-3% -$338K 0.74% 49
2015
Q2
$11M Sell
112,665
-3,583
-3% -$359K 0.72% 48
2015
Q1
$11.7M Buy
116,248
+708
+0.6% +$72K 0.78% 46
2014
Q4
$12.1M Buy
115,540
+786
+0.7% +$82.8K 0.83% 45
2014
Q3
$12.2M Sell
114,754
-1,210
-1% -$125K 0.9% 47
2014
Q2
$12.1M Sell
115,964
-428
-0.4% -$43.3K 0.89% 46
2014
Q1
$11.4M Buy
116,392
+1,513
+1% +$140K 0.86% 47
2013
Q4
$10.5M Sell
114,879
-3,433
-3% -$316K 0.8% 48
2013
Q3
$10.3M Buy
118,312
+1,850
+2% +$166K 0.82% 47
2013
Q2
$10M Buy
+116,462
New +$9.88M 0.84% 46

Other funds holding JNJ

Washington Trust's JNJ Position: Q1 2026 in Review

Washington Trust reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, selling an estimated $402K and leaving 105,717 shares worth $25.8M. The position accounts for 0.87% of the portfolio, ranked #30.

Washington Trust first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $30M in Q1 2021. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Washington Trust held 105,717 shares of Johnson & Johnson worth $25.8M as of Q1 2026.
  • Washington Trust sold 1,728 Johnson & Johnson shares in Q1 2026, an estimated $402K.
  • Johnson & Johnson made up 0.87% of Washington Trust's portfolio in Q1 2026, its #30 holding.
  • Washington Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Washington Trust's Johnson & Johnson position peaked at $30M in Q1 2021.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Washington Trust's 13F filing for Q1 2026, filed 6 Apr 2026.